patent/EP-2631249-A2

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2631249-A2

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b4a80ac02f1ecd0e698ec665e9b36b6
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-31
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
filingDate	2011-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df2a46b9a93ab80d681597cfa31eb3b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67bc2c6fefbefa1703e6b8aae9125cf9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b0332ebed176904f64d6934a6982795 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d889dad1017d6b68f17d5d84ed43e4ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d7b9daf3a426098d3eea647e79da82a
publicationDate	2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-2631249-A2
titleOfInvention	Fusion protein having factor ix activity
abstract	Disclosed is a fusion protein comprising blood coagulation factor IX (FIX) and transferrin. The fusion protein exhibits improved specific FIX activity, as compared to native FIX, and can be useful in the treatment of FIX deficiency-associated diseases.
priorityDate	2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007112005-A2
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395980 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20054941 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394092

Total number of triples: 34.